A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration
PHASE3
This multicenter study in participants with HER2-positive eBC will investig...
Status
Completed
Location
State Inst N.N. Alexandrov Republican Scientific & Practical Centre of Oncology & Medical Radiology
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
PHASE3
This single arm, multicenter study will evaluate the safety of assisted sub...
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
PHASE2
As a result of the little benefit obtained from standard treatments and the...
Status
Recruiting
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)